Journal Information
Vol. 101. Issue 4.
Pages 341-348 (May 2010)
Share
Share
Download PDF
More article options
Vol. 101. Issue 4.
Pages 341-348 (May 2010)
Original
Full text access
ATP-binding Cassette Transporter ABCB5 Gene is Expressed with Variability in Malignant Melanoma
Expresión variable del gen ABCB5 de las transportadoras de casetes de unión a ATP en el melanoma maligno
Visits
5291
I. Vásquez-Moctezumaa, M.A. Meraz-Ríosb, C.G. Villanueva-Lópeza, M. Magañac, R. Martínez-Maciasd, D.J. Sánchez-Gonzáleze, F. García-Sierraf, N.E. Herrera-Gonzáleza,
Corresponding author
neherrera@gmail.com

Corresponding author.
a Escuela Superior de Medicina, Instituto Politécnico Nacional, México DF, México
b Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), México DF, México
c Hospital General de México, Universidad Nacional Autónoma de México (UNAM), México DF, México
d Unidad de Oncología, Hospital General de México, México DF, México
e Escuela Médico Militar, Universidad de Falcan (UDEFA), México DF, México
f Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), México DF, México
This item has received
Article information
Abstract
Background

Melanoma is a malignant neoplasm with high metastatic disease risk and elevated mortality. Incidence of melanoma varies according to geographic region and genetic background. Epidemiological studies indicate that acral melanoma (AM) is among the most common melanomas in the Mexican population. While extensive studies have identified genes associated with melanoma, little is known about the genes involved in the pathogenesis of AM.

Objective

To compare the gene expression patterns between primary melanoma and normal skin.

Methods

We used 10 samples of fresh acral melanomas and normal skin for the study of differential gene expression and 22 samples of melanoma for in situ hybridization.

Results

We first identified a gene that was present in a sample of AM and absent in normal skin. DNA sequencing of this differentially expressed gene revealed that it corresponded to ABCB5, a gene recently implicated in the regulation of progenitor cell fusion. Furthermore, we detected ABCB5 expression in other melanoma specimens by RT-PCR. We showed that nine out of ten melanomas were positive for ABCB5 while only one melanoma and normal skin samples were negative. All ABCB5 expressing melanomas had variable gene expression according to in situ hybridization studies, suggesting that the ABCB5 gene may be differentially regulated by individual melanomas.

Conclusions

The ABCB5 gene may be related to the properties of chemoresistance and aggressiveness of melanoma. The high expression found in samples of acral melanoma may provide more insight on the pathogenesis of this common type of melanoma in the Mexican population, frequently associated with poor prognosis.

Keywords:
Melanoma
ABCB gene
Gene expression
Differential display
Resumen
Introducción

El melanoma es una neoplasia maligna que presenta una elevada mortalidad y un alto riesgo de desarrollar metástasis. La incidencia de esta enfermedad varía en función de la región geográfica y el trasfondo genético. Estudios epidemiológicos indican que el melanoma acral es uno de los más comunes en la población mexicana. Hay una gran cantidad de estudios sobre genes asociados al melanoma, sin embargo, se sabe muy poco de los genes que se relacionan con el melanoma acral.

Objetivo

Comparar el patrón de expresión génica entre melanomas acrales primarios y piel sana.

Métodos

Se utilizaron muestras en fresco de 10 lesiones de melanoma acral y piel sana para el estudio de expresión diferencial de genes y 22 muestras de melanoma para la hibridación in situ.

Resultados

Identificamos un gen que estaba presente en una muestra de melanoma acral y ausente en la piel normal. La secuenciación de este gen reveló que correspondía al gen ABCB5, recientemente implicado en la regulación de la fusión de células progenitoras. Al realizar RT-PCR de otros melanomas se detectó la expresión de este gen: 9 de 10 melanomas fueron positivos para ABCB5. Todos los melanomas tuvieron una expresión variable de ABCB5 detectado por hibridación in situ, lo cual sugiere que el gen puede ser regulado diferencialmente en melanomas individuales.

Conclusiones

El gen ABCB5 podría estar relacionado con las propiedades de resistencia a la quimioterapia y la agresividad del melanoma. La elevada expresión encontrada en las muestras de melanoma acral podría ayudar a la mejor comprensión de la patogenia de esta forma frecuente de melanoma en la población mexicana, que se asocia generalmente con un peor pronóstico.

Palabras clave:
Melanoma
Gen ABCB5
Expresión génica
Expresión diferencial de genes
Full text is only aviable in PDF
References
[1.]
M. Lens, M. Dawes.
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma.
Br J Dermatol, 150 (2004), pp. 179-185
[2.]
M. Magaña, J. Cazarín, L. Magaña.
Características del melanoma en la población mexicana.
Actas Dermatol Dermatopathol (Méx), 1 (2001), pp. 59-62
[3.]
F. Meier, K. Satyamoorthy, M. Nesbit, M.Y. Hsu, B. Schittek, C. Garbe, et al.
Molecular events in melanoma development and progression.
Front Biosci, 3 (1998), pp. 1005-1010
[4.]
B. Bastian, A. Olshen, P. LeBoit, D. Pinkel.
Classifying melanocytic tumors based on DNA copy number changes.
Am J Pathol, 3 (2003), pp. 1765-1770
[5.]
W. Berger, L. Elbling, M. Minai-Pour, M. Vetterlein, R. Pirker, E.M. Kokoschka, et al.
Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines.
Int J Cancer, 59 (1994), pp. 717-723
[6.]
S. Ambudkar, S. Dey, C. Hrycyna, M. Ramachandra, I. Pastan, M.M. Gottesman.
Biochemical, cellular, and pharmacological aspects of the multidrug transporter.
Annu Rev Pharmacol Toxicol, 39 (1999), pp. 361-398
[7.]
R. Juliano, V. Ling.
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.
Biochemical Biophysical Acta, 455 (1976), pp. 152-162
[8.]
A. Fojo, K. Ueda, D. Slamon, D.G. Poplack, M.M. Gottesman, I. Pastan.
Expression of a multidrug-resistance gene in human tumors and tissues.
Proc Natl Acad Sci USA, 84 (1978), pp. 265-269
[9.]
M. Dean, A. Rzhetsky, R. Allikmets.
The human ATP-binding cassette (ABC) transporter superfamily.
Genome Res, 11 (2001), pp. 1156-1166
[10.]
D. Shen, A. Fojo, I. Roninson, J.E. Chin, R. Soffir, I. Pastan, et al.
Multidrug resistance of DNA mediated transformants is linked to transfer of the human mdr1 gene.
Mol Cell Biol., 6 (1986), pp. 4039-4045
[11.]
T. Schatton, G. Murphy, N. Frank, K. Yamaura, A.M. Waaga-Gasser, M. Gasser, et al.
Identification of cells initiating human melanomas.
Nature, 451 (2008), pp. 345-349
[12.]
S. Hoffmeyer, O. Burk, O. Von Ritcher, H.P. Arnold, J. Brockmóller, A. Johne, et al.
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of the one allele with P-glycoprotein expression and activity in vivo.
Proc Natl Acad Sci USA, 97 (2000), pp. 3473-3478
[13.]
M. Soengas, S. Lowe.
Apoptosis and melanoma chemoresistance.
Oncogene, 23 (2003), pp. 3138-3151
[14.]
P. Liang, A. Pardee.
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.
Science, 257 (1992), pp. 967-971
[15.]
J. Lohmann, H. Schickle, T. Bosch.
REN display, a rapid and efficient method for nonradioactive differential display and mRNA isolation.
Biotechniques, 18 (1995), pp. 200-202
[16.]
N. Frank, S. Pendse, P. Lapchak, A. Margaryan, D. Shlain, C. Doeing, et al.
Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter.
J Biol Chem, 278 (2003), pp. 47156-47165
[17.]
Y. Huang, P. Anderle, K. Bussey, C. Barbacioru, U. Shankavaram, Z. Dai, et al.
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance.
Cancer Res, 64 (2004), pp. 4294-4301
[18.]
J. Kurebayashi, T. Otsuki, H. Kunisue, K. Tanaka, S. Yamamoto, H. Sonoo, et al.
Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Clin Cancer Res, 6 (2000), pp. 512-518
[19.]
M. Maia, C. Russo, N. Ferrari, M.C.S.A. Ribeiro.
Acral lentiginous melanoma: a challenge for early diagnosis.
An Bras Dermatol, 78 (2003), pp. 553-560
[20.]
B.E. Gonzalez, E. Ziv, N. Coyle, S.L. Gomez, H. Tang, A.J. Karter, et al.
The importance of race and ethnic background in biomedical research and clinical practice.
N Engl J Med, 348 (2003), pp. 1170-1175
[21.]
R. Cooper, J. Kaufman, R. Ward.
Race and genomics.
N Engl J Med, 248 (2003), pp. 1166-1170
[22.]
B. Bastian, P. LeBoit, H. Hamm, E.B. Brocker, D. Pinkel.
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.
Cancer Res, 58 (1998), pp. 2170-2175
[23.]
B. Bastian, P. LeBoit, D. Pinkel.
Genomic approaches to skin cancer diagnosis.
Arch Dermatol, 137 (2001), pp. 1507-1511
[24.]
H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, et al.
Mutation of the B-RAF gene in human cancer.
Nature, 417 (2002), pp. 949-954
[25.]
J. Maldonado, J. Fridlyand, H. Patel, A.N. Jain, K. Busam, T. Kageshita, et al.
Determinants of B-RAF mutations in primary melanomas.
J Natl Cancer Inst, 95 (2003), pp. 1878-1890
[26.]
M. Liscovitch, Y. Lavie.
Cancer multidrug resistance: a reviewof recent drug discovery research.
Drugs, 5 (2002), pp. 349-355
[27.]
K. Chen, G. Szakács, J. Annereau, F. Rouzaud, X.J. Liang, J.C. Valencia, et al.
Principal expression of two mRNA isoforms, (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB5 in melanoma cells and melanocytes.
Pigment Cell Res, 18 (2005), pp. 102-112
[28.]
N. Frank, A. Margaryan, Y. Huang, T. Schatton, A.M. Waaga-Gasser, M. Gasser, et al.
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Cancer Res, 65 (2005), pp. 4320-4333
[29.]
G. Giaccone, H. Pinedo.
Drug resistance.
Oncologist, 1 (1996), pp. 82-87
[30.]
R. Weinstein, S. Jakate, J. Domínguez, M. Lebovitz, G. Koukoulis, J. Kuszak, et al.
Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis.
Cancer Res, 51 (1991), pp. 2720-2726
[31.]
K. Chen, J. Valencia, B. Lai, G. Zhang, J.K. Paterson, F. Rouzaud, et al.
Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.
Proc Natl Acad Sci USA, 103 (2006), pp. 9903-9907
[32.]
C. Perniciaro.
Dermatopathologic variants of malignant melanoma.
Mayo Clin Proc, 3 (1997), pp. 273-279
[33.]
M. Poetsch, C. Woenckhaus, T. Dittberner, M. Pambor, G. Lorenz, F.H. Herrmann.
Significance of the small subtelomeric area of chromosome 1, (1p36.3) inthe progression of malignant melanoma: FISH deletion screening with YAC DNA probes.
Virchows Arch, 435 (1999), pp. 105-111
[34.]
J. Sohn, S. Lee, S. Lee, E.J. Kim, S.I. Cha, Ch.H. Kim, et al.
MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer.
Jpn J Clin Oncol, 36 (2006), pp. 137-141
[35.]
L. Duncan, J. Deeds, J. Hunter, J. Shao, L.M. Holmgren, E.A. Woolf, et al.
Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
Cancer Res, 58 (1998), pp. 1515-1520
[36.]
M. Rodolfo, M. Daniotti, V. Vallacchi.
Genetic progression of metastatic melanoma.
Cancer Lett, 214 (2004), pp. 133-147
Copyright © 2010. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?